ADMA Biologics Inc (NAS:ADMA)
$ 10.49 0.4 (3.96%) Market Cap: 2.43 Bil Enterprise Value: 2.44 Bil PE Ratio: 0 PB Ratio: 15.89 GF Score: 65/100

Q4 2019 ADMA Biologics Inc Earnings Call Transcript

Mar 12, 2020 / 08:30PM GMT
Release Date Price: $2.19 (-5.19%)
Operator

Good afternoon, and welcome to the ADMA Biologics Fourth Quarter and Full Year 2019 Financial Results Conference call on Thursday, March 12, 2020. (Operator Instructions) Please be advised that this call is being recorded at the company's request and will be available on the company's website approximately 2 hours following the end of the call.

At this time, I would like to introduce Mr. Sam Martin, Managing Director of Argot Partners, ADMA's Investor Relations firm. Sir, please go ahead.

Samuel Martin
Argot Partners, LLC - MD

Thank you, Joanna. Welcome, everyone, and thank you for joining us this afternoon to discuss ADMA Biologics' financial results for the fourth quarter and full year 2019. I'm joined today by Adam Grossman, President and Chief Executive Officer; and Brian Lenz, Executive Vice President and Chief Financial Officer.

During today's call, Adam will provide some introductory comments and provide a corporate update, and then Brian will provide an overview of our fourth quarter and full year 2019 financial results. Adam will

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot